1,002
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

A single-centre study of frame-based stereotactic brain biopsies

ORCID Icon, , &
Pages 213-216 | Received 26 Apr 2020, Accepted 18 Dec 2020, Published online: 11 Jan 2021

References

  • Nishihara M, Takeda N, Harada T, et al. Diagnostic yield and morbidity by neuronavigation-guided frameless stereotactic biopsy using magnetic resonance imaging and by frame-based computed tomography-guided stereotactic biopsy. Surg Neurol Int 2014;5:S421–S6.
  • Lu Y, Yeung C, Radmanesh A, Wiemann R, Black PM, Golby AJ. Comparative effectiveness of frame-based, frameless, and intraoperative magnetic resonance imaging–guided brain biopsy techniques. World Neurosurgery 2015;83:261–8.
  • Dammers R, Haitsma IK, Schouten JW, Kros JM, Avezaat CJ, Vincent AJ. Safety and efficacy of frameless and frame-based intracranial biopsy techniques. Acta Neurochir 2008;150:23–9.
  • Bradac O, Steklacova A, Nebrenska K, Vrana J, de Lacy P, Benes V. Accuracy of VarioGuide Frameless Stereotactic System against frame-based stereotaxy: prospective, randomized, single-center study. World Neurosurg 2017;104:831–40.
  • Julià-Sapé M, Acosta D, Majos C, et al. Comparison between neuroimaging classifications and histopathological diagnoses using an international multicenter brain tumor magnetic resonance imaging database. J Neurosurg 2006;105:6–14.
  • Riche M, Amelot A, Peyre M, Capelle L, Carpentier A, Mathon B. Complications after frame-based stereotactic brain biopsy: a systematic review. Neurosurg Rev 2020 Jan 4. Epub ahead of print.
  • Jackson RJ, Fuller GN, Abi-Said D, et al. Limitations of stereotactic biopsy in the initial management of gliomas. Neuro Oncol 2001;3:193–200.
  • Quick-Weller J, Tichy J, Harter PN, et al. “Two is not enough” - impact of the number of tissue samples obtained from stereotactic brain biopsies in suspected glioblastoma. J Clin Neurosci 2018;47:311–4.
  • Hakan T, Aker FV. Evaluation of 126 consecutive stereotactic procedures: brain biopsy, diagnostic yield, accuracy, non-diagnostic results, complications and follow-up. Turk Neurosurg 2016;26:890–9.
  • Chen CC, Hsu PW, Erich Wu TW, et al. Stereotactic brain biopsy: single center retrospective analysis of complications. Clin Neurol Neurosurg 2009;111:835–9.
  • Neumann JO, Campos B, Younes B, et al. Frame-based stereotactic biopsies using an intraoperative MR-scanner are as safe and effective as conventional stereotactic procedures. PLoS One 2018;13:e0205772.
  • Hamisch CA, Minartz J, Blau T, et al. Frame-based stereotactic biopsy of deep-seated and midline structures in 511 procedures: feasibility, risk profile, and diagnostic yield. Acta Neurochir 2019;161:2065–71.
  • Dammers R, Schouten JW, Haitsma IK, Vincent AJPE, Kros JM, Dirven CMF. Towards improving the safety and diagnostic yield of stereotactic biopsy in a single centre. Acta Neurochir 2010;152:1915–21.
  • Schlegel U. Primary CNS lymphoma. Ther Adv Neurol Disord 2009;2:93–104.
  • Grommes C, DeAngelis LM. Primary CNS lymphoma. J Clin Oncol 2017;35:2410–8.
  • Callovini GM, Telera S, Sherkat S, Sperduti I, Callovini T, Carapella CM. How is stereotactic brain biopsy evolving? A multicentric analysis of a series of 421 cases treated in Rome over the last sixteen years. Clin Neurol Neurosurg 2018;174:101–7.
  • Jakola AS, Myrmel KS, Kloster R, et al. Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas. JAMA 2012;308:1881–8.
  • Jakola AS, Unsgard G, Myrmel KS, et al. Surgical strategy in grade II astrocytoma: a population-based analysis of survival and morbidity with a strategy of early resection as compared to watchful waiting. Acta Neurochir 2013;155:2227–35.
  • Jakola AS, Skjulsvik AJ, Myrmel KS, et al. Surgical resection versus watchful waiting in low-grade gliomas. Ann Oncol 2017;28:1942–8.
  • Tsankova NM, Canoll P. Advances in genetic and epigenetic analyses of gliomas: a neuropathological perspective. J Neurooncol 2014;119:481–90.
  • Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016;131:803–20.